Base Genomics

📍 Oxford, United Kingdom🗓 Founded 2019💰 Last funded Apr 2019
Biotechnology Research🌐 basegenomics.com
Website LinkedIn
Base Genomics is a new start-up that aims to have a major impact on personalised medicine. We are developing TAPS, a breakthrough technology from the University of Oxford that makes epigenetic analysis of DNA methylation more sensitive, accurate and cheaper than ever before. We aim to transform healthcare by enabling early and precise detection of cancer. Long-term, we expect TAPS to become central to a host of major new healthcare and research applications. *We are hiring* We are looking for talented chemists, enzymologists, protein engineers, NGS specialists, bioinformaticians and software developers at all levels. Check out the available roles at basegenomics.com/join-us
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2019
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in Base Genomics?
Base Genomics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Base Genomics last raise funding?
The most recent investment in Base Genomics recorded on gritt.io was in April 2019.
When was Base Genomics founded?
Base Genomics was founded in 2019.
What industry is Base Genomics in?
Base Genomics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Base Genomics based?
Base Genomics is headquartered in Oxford, United Kingdom.